Thursday, September 14, 2017

AstraZeneca succeeds in omeprazole patent infringement profits case

JD Supra (press release)-16 hours ago
While both parties agreed that a profits on profits allowance was appropriate, they disagreed as to the appropriate rate and whether it ought to be compounded.

No comments: